Digby-Bell, Jonathan L.
Atreya, Raja
Monteleone, Giovanni
Powell, Nick
Article History
Accepted: 14 October 2019
First Online: 25 November 2019
Competing interests
: R.A. discloses consultancy fees, grants or personal fees from AbbVie, Biogen, Boehringer Ingelheim, Dr Falk Pharma, Ferring, InDex Pharmaceuticals, Janssen-Cilag, MSD, Pfizer, Roche Pharma, Samsung Bioepsis, Stelic Institute, Takeda and Tillotts Pharma. J.L.D.-B. declares receiving speaker fees from Abbvie and Takeda and conference fees from MSD and Shield. N.P. declares advisory and/or speaker fees from Abbvie, Allergan, Celgene, Debiopharm, Ferring and Vitor Pharma, and lecture fees from Allergan, Dr Falk Pharma, Janssen, Takeda and Tillotts. G.M. declares no competing interests.